Shilpa Medicare gets USFDA nod for cancer drug
The company has received US FDA final approval for its ANDA for Docetaxel Injection USP in the strengths of 20 mg/mL, 80 mg/4 mL…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon and Mylan to announce the final overall survival data for Ogivri
Ogivri is the first biosimilar for Herceptin approved by the US Food and Drug Administration (FDA) for all indications including…
Pfizer’s atopic dermatitis treatment meets goals in late-stage study
The drug developed by the firm, Abrocitinib, was found to have significantly improved clearing of the skin in patients as compared…
Scientists in new push to control cancer before curing it
Centre for Cancer Drug Discovery, a new centre being set up will “seek to meet the challenge of cancer evolution head on” by…
Lupin gets 3 observations from USFDA for Aurangabad plant
The USFDA carried out the inspection at the plant from May 6 to May 15
Dr. Reddy’s launches Daptomycin for Injection in US
Daptomycin for Injection is a a therapeutic equivalent generic version of Cubicin for Injection
IDMA organises Marketing and Sales Conference, 2019 in Mumbai
The theme of this year's conference was “Growing Brands to Level Next”
LifeArc and GVK BIO celebrate 10 years of partnership
The longevity of this partnership, and the transformative results of the collaboration, serve as a testament to the capabilities…
Reimagining biopharma R&D and clinical trials in the age of AI
World Clinical Trials Day, May 20, marks the date of the first randomised clinical trial, held aboard a ship in 1747. Today, as…